Entecavir is safe and effective in long term for the treatment of hepatitis B in immunocompromised children
ConclusionEntecavir is safe and effective in long term for the treatment of hepatitis B in immunocompromised children.
Source: Journal of Clinical and Experimental Hepatology - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Children | Gastroenterology | Hepatitis | Hepatitis B | Study | Virology